SCHEMBL23516508

SCHEMBL23516508

CN1C(=O)c2cccc(-n3c4ccccc4c4cc(-c5cccnc5)ccc43)c2C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B2 P19099 5/20 0.43
▸ CYP11B1 P15538 4/20 0.43
▸ CYP19A1 P11511 2/20 0.42
▸ CYP17A1 P05093 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ GSK3B P49841 2/20 0.41
▸ NR4A2 P43354 1/20 0.41
▸ MAPK14 Q16539 1/20 0.40
▸ BACE1 P56817 4/20 0.39
▸ METAP2 P50579 1/20 0.39
▸ PGR P06401 1/20 0.38
▸ CHEK1 O14757 2/20 0.38
▸ HRH1 P35367 1/20 0.38
▸ HTR6 P50406 1/20 0.38
▸ AURKA O14965 1/20 0.37
▸ DAPK3 O43293 1/20 0.37
▸ JAK2 O60674 1/20 0.37
▸ PRKD3 O94806 1/20 0.37
▸ MAP4K4 O95819 1/20 0.37
▸ PAK4 O96013 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23515971 0.96 CYP11B1 (0.45) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL23516515 0.94 METAP2 (0.43) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL23516097 0.89 MAPK14 (0.41) GSK3BNR4A2MAPK14METAP2MAP4K4
SCHEMBL19852617 0.89 MEN1 (0.36) —
SCHEMBL23515966 0.89 METAP2 (0.46) CYP11B2CYP11B1CYP19A1CYP17A1CYP1A2
SCHEMBL23516476 0.88 ALDH1A1 (0.44) CYP11B2CYP11B1NR4A2MAPK14METAP2
SCHEMBL23516506 0.87 MAPK14 (0.45) CYP11B2CYP11B1GSK3BMAPK14
SCHEMBL23516226 0.87 KDM4E (0.43) CYP11B2CYP11B1NR4A2MAPK14METAP2
SCHEMBL23516275 0.86 KDM4E (0.41) CYP11B2CYP11B1MAPK14METAP2
SCHEMBL23515969 0.85 MAPK14 (0.43) CYP11B2GSK3BMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276825-B2 Organic molecules for use in organic devices CYNORA GMBH (DE) 2022-03-15 — — US disclosed
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES CHRM1, C1S, DNMT3L CYP11B2 740/4885CYP11B1 386/4885CYP19A1 1261/4885
US-11276825-B2 Organic molecules for use in organic devices AOX1, OR10J3, L1CAM CYP11B2 545/4885CYP11B1 557/4885CYP19A1 443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback